Clinical trial
The BRAVE Study: Borg Score Outcomes in Respiratory Compromised Acute Exacerbating COPD Patients Receiving Treatment Via Vibrating Mesh Nebuliser Versus Jet Nebuliser in the Emergency Department
NCT04181073 is registered in ClinicalTrials.gov with NHS Greater Clyde and Glasgow as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The BRAVE Study: Borg Score Outcomes in Respiratory Compromised Acute Exacerbating COPD Patients Receiving Treatment Via Vibrating Mesh Nebuliser Versus Jet Nebuliser in the Emergency Department
- Lead sponsor
- NHS Greater Clyde and Glasgow
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2019
- Completion date
- October 31, 2021
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
copd, copd exacerbation